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Edited by Felix WielandAbstract We identiﬁed a novel mutation Ala178fs/105 missing
S3–S6 and C-terminus portions of KCNQ1 channel. Ala178fs/
105-KCNQ1 expressed in COS-7 cells demonstrated no current
expression. Co-expression with wild-type (WT) revealed a
dominant-negative eﬀect, which suggests the formation of
hetero-multimer by mutant and WT. Confocal laser microscopy
displayed intracellular retention of Ala178fs/105-KCNQ1 pro-
tein. Co-expression of the mutant and WT also increased
intracellular retention of channel protein compared to WT alone.
Our ﬁndings suggest a novel mechanism for LQT1 that the
truncated S1–S2 KCNQ1 mutant forms hetero-multimer and
cause a dominant-negative eﬀect due to traﬃcking defect.
 2004 Published by Elsevier B.V. on behalf of the Federation of
European Biochemical Societies.
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death1. Introduction
Long QT syndrome (LQTS) is characterized by QT pro-
longation, syncope, and sudden cardiac death due to poly-
morphic ventricular tachyarrhythmias. Mutations in KCNQ1
gene cause the most frequent form long QT syndrome type 1
(LQT1) of inherited LQTS. So far, more than 100 mutations
have been identiﬁed and various mechanisms of channel dys-
function are implicated [1]. Among the factors causing channel* Corresponding author. Fax: +81-3-5684-6295.
E-mail address: hiraoka-masayasu@mhlw.go.jp (M. Hiraoka).
Abbreviations: LQTS, long QT syndrome; LQT1, long QT syndrome
type 1; ECG, electrocardiogram; DNA, deoxyribonucleic acid; PCR,
polymerase chain reaction; SSCP, single-strand conformation poly-
morphism; WT, wild-type; cDNA, complementary deoxyribonucleic
acid; CFP, cyan ﬂuorescent protein; YFP, yellow ﬂuorescent protein;
S.E.M., standard error of mean
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doi:10.1016/j.febslet.2004.08.018dysfunction, traﬃcking defect of channel protein in KCNQ1 is
rare as compared to the cases of KCNH2 (HERG) mutations.
We identiﬁed several novel mutations in KCNQ1 and KCNH2
from Japanese LQTS patients. One of the patients who showed
severe phenotype disclosed a frameshift mutation resulting in
the truncation of KCNQ1 channel to the S1–S2 portion. We
evaluated functional properties of this frameshift mutation
expressed in COS-7 cells.2. Materials and methods
2.1. A case presentation
A 13-year-old girl was referred to our institute for genetic analysis.
She had a history of cardiopulmonary arrest while during swimming in
the pool. Her hearing ability was normal and she had no family history
of syncope or sudden cardiac death. Her electrocardiogram (ECG)
showed broad-based and high amplitude T wave. QTc interval at
baseline was 0.52 s (Fig. 1) and it further prolonged with exercise up to
0.62 s. The b-blocking drug, propranolol, is eﬀective in suppressing
recurrent arrhythmic events.
2.2. Genetic analysis
The study was approved by the Ethics Reviewing Committee of
Medical Research Institute, Tokyo Medical and Dental University.
After written informed consent was obtained, the genomic deoxyri-
bonucleic acid (DNA) was isolated from peripheral blood lymphocytes
by conventional methods. The genomic DNA was ampliﬁed on
GeneAmpR PCR System 9700 thermal cycler by standard polymerase
chain reaction (PCR) technique using the primers as described previ-
ously [2]. For the genetic screening, we used single-strand conforma-
tion polymorphism (SSCP) followed by DNA sequencing method as
for KCNQ1, KCNH2, SCN5A, KCNE1 and KCNE2 genes. Abnormal
conformers were sequenced with ABI377XL genetic analyzer (Applied
Biosystems). Electropherograms were compared with the KCNQ1
wild-type (WT) sequence (GenBank Accession No. AJ006343) using
the DNASIS Ver. 3.7 software (HITACHI). Genetic screening for her
family members was not available.
2.3. Wild type- and mutant-KCNQ1 constructs
The WT KCNQ1 and KCNE1 complementary deoxyribonucleic
acids (cDNAs) were ampliﬁed from the adult heart cDNA of Human
Cardiovascular MTC PanelTM (BD Biosciences Clontech) by PCR
using primer pairs; KCNQ1-forward/reverse (50-GGATCCGTT-ation of European Biochemical Societies.
Fig. 1. ECG of the patient at rest. QTc interval was prolonged to
0.52 s.
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GGCCCTCC-30) and KCNE1-forward/reverse (50-CAGGATGAT-
CCTGTCTAACACC-30 and 50-GGATCCTCATGGGGAAGGCT-
TCGT-30), respectively (artiﬁcial BamHI sites and the initiation
codons are underlined). The PCR products were cloned into pCR2.1
vector (Invitrogen CA). The substitution of GG for C found in the
Ala178fs/105 (A178fs/105) mutant-KCNQ1 was introduced to WT-
KCNQ1 cDNA by overlap extension using the PCR [3]. In brief, the
mutagenic oligonucleotides for the A178fs/105 substitution are A178fs-
forward (50-TCTGGTCCGGGCGGCTGCCGCA-30) and A178fs-
reverse (50-TGCGGCAGCCGCCCGGACCAGA-30, underlines
indicate the site of mutation). The two PCR products with KCNQ1-
forward and A178fs-reverse primers and A178fs-forward and A178fs-
reverse (50-TCTAGACTCGTTCACCGCGTCCTTCT-30, XbaI site
added is underlined) primers were mixed and subjected to ligation PCR
using ﬂanking primers, KCNQ1-forward and A178fs-reverse. The re-
sultant PCR fragment, which spans from the initiation codon to the
premature termination codon, appeared in the mutant at position +105
and was cloned into pCR2.1 vector. For electrophysiological studies,
the BamHI–EcoRI fragment containing WT- or mutant-KCNQ1
coding sequence was excised from the corresponding pCR2.1 cDNA
clone and inserted to an expression vector pcDNA3.1(+) (Invitrogen).
For confocal microscopic analysis, BamHI–XbaI fragment of cDNA
clone was ligated to BamHI–XbaI cleaved cyan ﬂuorescent protein
(CFP) or yellow ﬂuorescent protein (YFP) expression vector pECFP-
C1 or pEYFP-C1 (BD Biosciences Clonetech). For KCNE1 cDNA
expression, BamHI–EcoRI fragment of the cDNA clone was inserted
into pcDNA3.1(+) expression vector. All the inserts of plasmid vectors
used in this study were sequenced to ensure that no PCR error was
introduced.
2.4. Cell culture and transient transfection
A cell line COS-7 was obtained from American Type Cell Collection
and cultured in Dulbecco’s modiﬁed Eagle’s medium (Invitrogen)
supplemented with 10% fetal bovine serum and 1% penicillin–strep-
tomycin in a humidiﬁed 5% CO2 incubator at 37 C. Cultured cells
were seeded in 60-mm dishes 1 day before transfection and transiently
transfected with various plasmids by lipofectamine method using theSuperFect Transfection Reagent (QIAGEN). In the electrophysiologic
experiments, 1.25 or 0.625 lg of WT-KCNQ1 (cloned into pcDNA3.1),
0.625 lg WT- and 0.625 lg mutant-KCNQ1 (cloned into pcDNA3.1),
and 1.25 lg mutant-KCNQ1 were used alone with the same amount of
KCNE1 (cloned into pcDNA3.1). pEGFP-C1 was co-transfected to
allow for identiﬁcation of the transfected cells. Cells displaying green
ﬂuorescence 24–48 h after transfection were used for the electrophys-
iologic experiments.
2.5. Electrophysiological recordings
Whole-cell patch-clamp method was applied to COS-7 cells trans-
fected with WT- and/or mutant-KCNQ1 channel as described previ-
ously [4]. Brieﬂy, cells were allowed to settle on the bottom of bath (0.5
mL) mounted on an inverted microscope (Diaphoto TMD, Nikon).
Cells were superfused with normal Tyrode’s solution containing (in
mmol/L) 144 NaCl, 0.33 NaH2PO4, 4 KCl, 1.8 CaCl2, 0.53 MgCl2, 5.5
Glucose and 5.0 HEPES (pH 7.4 adjusted with NaOH). The glass
pipettes had an inner diameter of 1.0–1.5 lm andd resistance of 2–3
MX when ﬁlled with the internal solution. The internal solution con-
tained (in mmol/L) 100 K-aspartate, 20 KCl, 5 ATP-Mg, 5CP-K2, 5
EGTA, 5 HEPES and 1 CaCl2 (pH 7.2 adjusted with KOH). A patch-
clamp ampliﬁer (Axopatch 200B, Axon Instruments) was used to re-
cord membrane currents. After forming a whole-cell conﬁguration, cell
membrane capacitance was estimated by analyzing capacity transient
elicited by 5 mV hyperpolarizing pulses. Series resistance compensa-
tion was done by 50–70% using the circuit built into the ampliﬁer
(Axopatch 200B). Cells were held at holding potential of )80 mV and
depolarizing pulses to various potentials ranging from )40 to +70 mV
in 10 mV increments for 7.5 s were applied followed by repolarization
to )50 mV for 2 s to record tail currents. Software (pCLAMP 8.0,
Axon Instruments) was used to generate pulse protocol, data acqui-
sition and analysis. All experiments were done at room temperature
(22–24 C).
2.6. Confocal microscopy
CFP-tagged WT-KCNQ1 and YFP-tagged mutant-KCNQ1 were
transfected to COS-7 cells in glass-bottomed well slide (Lab-Tek).
Forty-eight hours after the transfection, cells were ﬁxed on slide-glass
with 4% paraformaldehyde and visualized using LSM510 confocal
laser scanning microscope (Carl Zeiss). Argon laser was used to excite
the CFP (excitation wavelength¼ 458 nm) and YFP (excitation
wavelength¼ 514 nm). CFP ﬂuorescence was detected with the BP465/
495 ﬁlter set and assigned as blue. YFP ﬂuorescence was detected with
the BP535/565 ﬁlter set and assigned as yellow. Merged image was
obtained by overlaying images from individual channels using
LSM510 confocal laser scanning microscope was assigned as white.
2.7. Data analysis
All data were expressed as meansS.E.M. Student’s t test was
performed for statistical evaluation. P < 0:05 was considered
signiﬁcant.3. Results
3.1. Mutational analysis
Abnormal bands were detected by the SSCP method in exon
3 of KCNQ1 (Fig. 2A) . The sequence of abnormal fragment
revealed a substitution of GG for C at position 533 in KCNQ1
(Fig. 2B). This abnormal sequence causes a reading frameshift
at amino acid 178 alanine resulting in shortened open reading
frame, with additional 105 out of frame amino acid residues
(Ala178fs/105), thereby eliminating the portions of S3–S6 and
C-terminus of KCNQ1 channel (Fig. 2C). This mutation was
not detected in blood samples from 150 unrelated healthy
Japanese individuals.
3.2. Electrophysiological properties of mutant-KCNQ1 currents
The cells transfected with 1.25 lg of WT-KCNQ1 together
with 1.25 lg of KCNE1 exhibited slowly activating outward
current compatible with IKs in native cardiac myocytes
Fig. 2. SSCP and electropherogram. (A) SSCP analysis detected abnormal band in the exon 3 of KCNQ1. (B) Electropherogram after sequencing of
index patient. A heterozygous C to GG transposition at the position of 533 nucleotides was conﬁrmed. (C) Schematic topology of KCNQ1 channels.
Because of the frameshift in the S2–S3 cytoplasmic loop, resulting premature stop codon deleted the S3–S6 including pore region and C-termini and
being replaced by additional 105 out of frame amino acid residues (thick gray line).
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KCNE1 did not produce any currents (Fig. 3D). The cells
transfected with 0.625 lg of WT-KCNQ1 (+KCNE1) expressed
the currents of nearly half amplitude of those with 1.25 lg of
WT-KCNQ1 (Fig. 3B). The co-expression of 0.625 lg of WT-
KCNQ1 with the same amount of mutant-KCNQ1 (+ KCNE1)Fig. 3. Representative current trace of WT- and/or A178fs/105 mutant-
KCNQ1 expressed in COS-7 cells. Cells of each panel were transfected
as follows: (A) 1.25 lg of WT-KCNQ1/pcDNA3.1(+) and 1.25 lg of
KCNE1/pcDNA3.1(+), (B) 0.625 lg of WT-KCNQ1/pcDNA3.1(+)
and 0.625 lg of KCNE1/pcDNA3.1(+), (C) 0.625 lg of WT-KCNQ1/
pcDNA3.1(+), 0.625 lg of A178fs/105 mutant-KCNQ1 /pcDNA3.1(+)
and 1.25 lg of KCNE1/pcDNA3.1(+). The initial portion of the cur-
rent traces (dashed square) was enlarged in the solid square. (D) 1.25
lg of A178fs/105 mutant-KCNQ1/pcDNA3.1(+) and 1.25 lg of
KCNE1/pcDNA3.1(+). Pulse protocol is shown in the inset on the top
right.showed much decreased amplitudes of currents compared to
those of 0.625 lg of WT-KCNQ1 (Fig. 3C).
The current–voltage relations of the peak current during
depolarizing pulses and the tail current upon repolarization to
)50 mV were summarized from pooled data in Fig. 4A and B.
The current–voltage relations were almost similar in shape
among 1.25 lg of WT-KCNQ1, 0.625 lg of WT-KCNQ1 and
0.625 lg of WT-KCNQ1 + mutant-KCNQ1, except for the
current densities. The densities of the peak currents with 0.625
lg of WT-KCNQ1 + KCNE1 were nearly half of those with
1.25 lg of WT-KCNQ1 at all test voltages (peak current at +60
mV; 16.6 4.4 pA/pF, n ¼ 9, and 34.5 3.6 pA/pF, n ¼ 21,
respectively). The current densities with 0.625 lg of WT- +
mutant-KCNQ1 were signiﬁcantly smaller than those with
0.625 lg of WT-KCNQ1 (3.9 2.3 pA/pF, n ¼ 5, p < 0:05 vs
0.625 lg WT-KCNQ1; both contained KCNE1) (Fig. 4C).
Thus, the current density generated by 0.625 lg of WT-
KCNQ1 + mutant-KCNQ1 was equivalent to about 11% of the
current induced by 1.25 lg of WT-KCNQ1. The densities of
tail current from +60 mV test pulse were 6.4 0.8 pA/pF in
1.25 lg of WT-KCNQ1 (n ¼ 21), 3.0 1.1 pA/pF in 0.625 lg
of WT-KCNQ1 (n ¼ 5) and 1.4 0.4 pA/pF in 0.625 lg of
WT-KCNQ1 + mutant-KCNQ1 (n ¼ 9) (Fig. 4D). The results
conﬁrmed that the mutant-KCNQ1 could suppress the func-
tion of WT-KCNQ1 in a dominant-negative manner.
The voltage dependence of activation WT-KCNQ1 (1.25 lg)
gave in value (the V0:5) of +23.4 1.3 mV and slope factor of
13.5 1.2 mV (n ¼ 21), which were ﬁtted with Boltzmann
function: 1[1 + exp(V)V1=2)/k] (data not shown). These values
were comparable to the ﬁndings in previous studies [5]. We
could not analyze voltage dependence of activation or detailed
kinetics of the mutant-KCNQ1 with WT since extremely small
current amplitudes made an accurate estimation result. How-
ever, the time courses of current activation during depolarizing
Fig. 4. Current–voltage relationships of expressed currents. (A) Current–voltage relationship measured at the peak current during test depolarization.
(B) Current–voltage relationship measured at the tail current upon repolarization to )50 mV following test depolarization. (C) Bar graphs showing
current densities obtained from the peak current at +60 mV. (D) Bar graphs showing current densities obtained from the tail current upon repo-
larization to )50 mV from +60 mV test depolarization.
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similar to those in WT (see, Fig. 3C inset).
3.3. Expression of WT- and mutant-KCNQ1 channels in COS-7
cells
CFP-tagged WT-KCNQ1 channel was correctly distributed
to the plasma membrane (Fig. 5A). On the other hand, the
YFP-tagged mutant-KCNQ1 protein was retained in the cy-
toplasm and peri-nuclear space (Fig. 5B). Co-expression of
CFP-tagged WT- and YFP-tagged mutant-KCNQ1 demon-
strated that the CFP signal was retained intracellular space,
and the surface expression of CFP signal was signiﬁcantly re-
duced (Fig. 6A), and the YFP signal (mutant channel) was
retained in the cytoplasm (Fig. 6B). As shown in the merged
image (Fig. 6C), CFP-tagged WT- and YFP-tagged mutant
channel were co-localized suggesting that they formed com-
plexes.4. Discussion
We identiﬁed a novel KCNQ1 mutation, Ala178fs/105,
eliminating the S3–S6 and C-terminus portions of the channel
in case of LQT patient. While the mutant-KCNQ1 alone failed
to express functional channel, co-expression of WT- and mu-
tant-KCNQ1 produced much decreased channel current
compared to the same amount of WT-KCNQ1 channel alone,
suggesting that the mutant-KCNQ1 suppressed the function of
WT channel in a dominant-negative manner. Furthermore, the
results indicate that the truncated mutant KCNQ1 formed
hetero-tetramer with WT. The sub-cellular localization of the
CFP- or YFP-tagged channel proteins actually revealed the
intracellular retention of the mutant protein, as well as co-
expressed WT and the mutant protein.4.1. K-channel traﬃcking
Several diﬀerent mutations in KCNH2 were shown to cause
traﬃcking defects, and the mutations were mostly missense
mutations distributed in the C-terminus, although some mis-
sense mutations were located in the N-terminus, S5 or pore
regions [6]. Especially in the case of KCNH2 channel, the C-
terminal region including cyclic nucleotide binding domain is
essential for channel traﬃcking, because it contains crucial
sequence linked to the endoplasmic reticulum retention signal
and the interaction site with GM130 required for channel
protein traﬃcking [7]. On the contrary, the mechanism of
channel traﬃcking in KCNQ1 channel was not well charac-
terized because of rare incidence in the traﬃcking defect of this
channel. Similar to KCNH2 channel, the C-terminal region of
KCNQ1 channel may play a role in the channel traﬃcking,
because Yamashita et al. reported that a missense mutation,
Thr587Met, in the cytoplasmic region of KCNQ1 protein
caused a traﬃcking defect [8].
4.2. Dominant-negative suppression
Dominant-negative suppression is one of the mechanisms
for decreased current seen in the KCNQ1 mutations to form
hetero-multimer with WT [9]. The mutations in the pore region
and in the supporting S5 transmembrane region of the
KCNQ1 channel were thought to disrupt the potassium
transport and associated with a dominant-negative eﬀect
[10,11]. The novel Ala178fs/105 mutation in KCNQ1 described
here was predicted to lack the S3–S6, pore, and C-terminal
cytoplasmic regions. In transgenic mouse models, truncated N-
terminal fragments of K channels were shown to exhibit a
dominant-negative eﬀect [12]. Furthermore, it is reported that
the overexpression of another K channel gene compensate for
the defective phenotype [13]. These observations suggested the
importance of N-terminal region of KCNQ1 channel sup-
Fig. 5. Sub-cellular localization of WT- and mutant-KCNQ1 protein in COS-7 cells. Confocal microscopic images of CFP-tagged WT- and YFP-
tagged mutant-KCNQ1 channel are presented. (A) Blue signals indicate CFP-tagged WT-KCNQ1 channel expressed on the cell surface. (B) Yellow
signals indicate YFP-tagged mutant-KCNQ1 channel mainly expressed in the cytoplasm.
Fig. 6. Co-expression of WT- and mutant-KCNQ1 protein in COS-7 cells. (A) Co-expression of CFP-tagged WT-KCNQ1 and YFP-tagged mutant-
KCNQ1 channel. CFP was visualized by 458 nm of Argon laser. WT-KCNQ1 channel (blue signals) was retained in the cytoplasm. (B)
Co-expression of CFP-tagged WT-KCNQ1 and YFP-tagged mutant-KCNQ1 channel. YFP was visualized by 514 nm of Argon laser. The mutant-
KCNQ1 channel (yellow signals) was retained in the cytoplasm. (C) Merged image of (A) and (B) demonstrates the co-localization of WT- and
mutant-channels retained in the cytoplasm. (D) Transmitted light/DIC image of (A, B, C).
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tive manner.
Although detailed analysis for activation or inactivation
kinetics of mutant-KCNQ1 channel was not achieved the time
course of current activation and voltage dependency of WT-
and mutant-KCNQ1 (+KCNE1) appeared not much changed
from those of WT (+KCNE1) (Fig. 3A and C). The results
might indicate that decreased current amplitude is not caused
by a failure of subunit interaction and/or homo- and hetero-
multimeric assembly of the channel on the cell surface, but is
caused by the traﬃcking defect of the channel protein as
supported by the ﬁndings of the distribution of CFP- and
YFP-tagged channels (Fig. 5). A traﬃcking defect as a mech-
anism for a dominant-negative suppression was reported by
Ficker et al. [14].
4.3. KCNQ1 channel assembly
Our results provide another important aspect that the
truncated KCNQ1 mutant lacking S3–S6 and C-terminus of
the channel assembles with WT and conformed hetero-mul-
timer. Schmitt et al. reported deletion of the carboxy-terminal
subunit interaction domain (sid; residues 590–620) abolished
functional channel expression and attenuated dominant-neg-
ative eﬀect in co-expression studies [15]. The sid was also in-
dicated as a determinant of the subunit speciﬁcity of KCNQ
Kþ channel assembly [16]. The A178fs/105 mutant lacks the
entire C-terminus including this presumed interaction domain,
but it is able to assemble with WT causing a dominant-neg-
ative suppression. Our results may indicate the presence of
another interaction site for subunit assembly in KCNQ1
subunit and the function of this site might be inhibited or
inactivated by the interaction with some missing portion of
this mutant. Otherwise additional 105 out of frame amino
acid residues generated may play some role for channel as-
sembly. These explanations are to be clariﬁed by further
studies.
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